Steve E. Herndon

Steve Herndon practices at Charleston Pulmonary Associates PA in Charleston, South Carolina.

Steve Herndon's NPI, 1861516668, was assigned on March 19, 2007. Steve Herndon holds North Carolina license 2015-00278.

Steve Herndon's primary practice is Charleston Pulmonary Associates PA, at 125 Doughty St, Charleston, SC 29403 in Charleston County. The practice phone is (843) 577-6791.

Steve Herndon's primary practice is Charleston Pulmonary Associates PA in Charleston, South Carolina. Steve Herndon is also affiliated with MUSC Health University Medical Center. The medical group on file is Bon Secours St. Francis Hospital. Dmand AI also links Steve Herndon to 4 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Steve Herndon practices, 8 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Steve Herndon's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Steve Herndon's licenses on file in 2 states: North Carolina and South Carolina.

CMS data shows 2,663 Medicare services from Steve Herndon across 18 procedure codes in 2024, for 1,024 Medicare patients. Medicare paid $185,810 for them.

CMS counts 1,024 Medicare patients who saw Steve Herndon in 2024. The largest group is 65 to 74, with 432 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Steve Herndon's median patient age at 69, with 55% women.

In 2024, Steve Herndon wrote 3,266 Medicare Part D claims for 484 patients. 43% of them were for generic drugs. CMS names the drug for 3,109 of them, across 36 drugs with 11 or more claims each, at $1,365,243 in total drug cost. In 2023, CMS named 2,781 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Steve Herndon for performance year 2024, reported as part of a group. Steve Herndon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Steve Herndon as offering telehealth.

CMS Open Payments shows 524 general payments to Steve Herndon from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,198.